| Heart bypass patients experience improved outcomes when surgeons use radial artery |
| FDA approves new solution for reducing heart muscle damage after serious heart attacks |
| Hypertension and COVID-19: 4 key things patients should know |
| TAVR outcomes worse than expected at 11% of US facilities |
| EuroHeartCare 2020 canceled over COVID-19 concerns |
| For TAVR patients with AFib, antiplatelet medication linked to poorer outcomes |
| TAVR ‘viable and safe’ for patients with a bicuspid valve |
| As COVID-19 pandemic continues, healthcare groups call for government action on equipment shortages |
| 35% of US cardiologists suffer from burnout, 44% feel stressed |
| Exhaustion and solidarity: Cardiologists share experiences from front lines of COVID-19 pandemic |
| Risk of death skyrockets when COVID-19 patients have both CVD and myocardial injury |
| ‘A win-win for everyone’: Ultrasound technique provides improved arrhythmia assessments |
| ASPC launches new journal focused on preventive cardiology |
| Nearly half of all serious cardiac events among pregnant women with heart disease are preventable |
| Putting it all on the line: Caring for COVID-19 patients leads to depression, distress for healthcare workers |
| More cardiology conferences canceled over COVID-19 concerns |
| Fewer treatments, higher readmission rates: Tracking outcomes for homeless patients after heart attacks |
| Cardiac injury in COVID-19 patients associated with higher in-hospital mortality |
| AHA commits $2.5M to COVID-19 research |
| Cardiologist leading fight against COVID-19 dies |
| Diets including tofu, other plant proteins linked to lower heart disease risk |
| Canadian healthcare group updates stance on low-dose aspirin to prevent stroke, heart disease |
| Cardiologist nets huge profits selling COVID-19 tests, officials warn against using them |
| Exercising while social distancing: recommendations in the face of COVID-19 |
| Facing the future: 4 key takeaways from the 2020 Cardiovascular Leadership Survey |
| Statins reduce risk of developing HF from breast cancer therapies |
| Emergency cardiovascular care and COVID-19: What healthcare providers need to know |
| New clinical trial focused on pulmonary complications in COVID-19 patients |
| Heart patients have cause to be hypervigilant about COVID-19 |
| Hypertension-related CVD mortality spikes 72% in rural areas, 20% in metros |
| 4 key considerations for managing cardiovascular patients with or without COVID-19 |
| Abdominal stent graft solution from Endologix gains FDA approval |
| 24-hour blood pressure assessments provide little value |
| Mental stress associated with repeat heart attacks, death from heart disease |
| What the COVID-19 pandemic means for cath labs |
| Risk of death from stroke drops 24% |
| Making an impact: AHA outlines its role during COVID-19 pandemic |
| HF patients with type 2 diabetes can safely be treated with liraglutide |
| A new warning for heart patients as COVID-19 continues to spread |
| FDA updates warnings for cigarette packaging, advertisements—compliance required by June 2021 |
| E-cigarette interferes with user’s implantable cardiac device, creating potential for ‘fatal consequences’ |
| Patients with COVID-19 should keep taking key CVD medications |
| Stem cell therapy revives cardiac muscle damaged during heart attacks |
| Heart-failure patients lose years of life when air pollution is a neighbor |
| LVAD recipients see heightened risk of suicide |
| Data Dilemma: Taming Healthcare’s Beautiful Beast |
| Judge recommends revoking license of UCLA cardiologist accused of sexual assault |
| 90 Days a Dyad (or Triad): Strategies for Success & Errors to Avoid in the Crucial Early Days of Partnership |
| New Take on Transplant: Reconsidering Hepatitis C-infected Hearts for Donation |
| Heartbeat Health raises $8.2M to expand virtual CV care platform |
| Pop Goes the Pillbox: Will Polypharmacy Problems Limit the Adoption of SGLT2 Inhibitors? |
| Stirring the Pot: Cannabis & Cardiology—How & Why to Talk with Patients About Marijuana Use |
| Cardiovascular Leaders Survey: About the Survey |
| Cardiovascular Leaders Survey: Demographics |
| Oasis of Opportunity: Strategies for Managing Healthcare’s Data Deluge |
| Canadian cardiologists perform world’s 1st minimally invasive tricuspid valve replacement |
| Cardiovascular Leaders Survey: What Healthcare Leaders Think |
| Cardiovascular Leaders Survey: Key Findings |
| Cardiovascular Leaders Survey: Defining State-of-the-Art CVIS |
| Cardiovascular Leaders Survey: Survey at a Glance |
| ACC issues COVID-19 guidance for cardiologists |
| Cardiovascular Leaders Survey: Priorities of the Cardiovascular Service Line |
| Cardiovascular Leaders Survey: Contents |
| Hypertension ‘a key dangerous factor’ in COVID-19 mortality |
| Whether Actionable or Adorable, Data Takes Patience (& Patient-centeredness) |
| How one hospital is perfecting mechanical CPR in the ED |
| Non-US citizens less likely to receive treatment for CV ills |
| Certain combos of statins, antihypertensives lower dementia risk |
| EHRA 2020 in Vienna canceled over coronavirus concerns |
| Many older AFib patients prescribed inappropriately dosed DOACs |
| AHA criticized for faulty marketing partnership with Bayer |
| ACC.20/WCC canceled amid COVID-19 outbreak |
| The more evidence-based advice MI patients follow, the longer they survive |
| ACC, ATA push for expanded use of telehealth to fight COVID-19 |
| Music therapy improves stroke survivors’ dexterity, mood |
| What PET imaging can tell cardiologists about post-heart transplant survival |
| Despite other cancellations, ACC.20 is a go |
| Ablation continues to benefit patients with concomitant HF, AFib |
| Some CV drugs increase exposure, psychoactive effects of THC |
| Coronavirus worries force ESC to cancel upcoming conference |
| Less than ⅕ of US stroke patients have timely access to thrombectomy |
| Carcinogens found in 16 lots of metformin |
| Researchers ID new protein as contributor to sudden cardiac death |
| Blood flows differently through men’s, women’s hearts |
| Irregular sleep doubles risk for CVD |
| Opioid use disorder meds boost odds of recovery in endocarditis patients |
